People News

Ourself Names New CEO

Medical aesthetic veteran James Hartman previously served as chief commercial officer at Alastin.

Author Image

By: Lianna Albrizio

Associate Editor

Biotech beauty company Ourself has appointed Alastin Skincare’s former chief commercial officer James Hartman as CEO.

“I am thrilled and honored to build upon Ourself’s robust scientific foundation as we expand and drive growth within the market,” said Hartman. “Our patented delivery system promises to revolutionize the skincare industry, breaking free from decades-old technological limitations. I am excited to collaborate with aesthetic clinicians nationwide to bring this cutting-edge skincare technology to their practice and patients.”

Prior to joining Ourself, Hartman served as chief commercial officer at Alastin Skincare. Under his leadership, the company achieved growth in the physician-dispensed skincare market, expanding its customer footprint by 30-fold, according to the brand. Officials said his strategic initiatives and development of an innovative market portfolio consistently drove revenue increases exceeding 110% annually, leading to company success and setting the stage for the acquisition by Galderma.

He also held leadership positions at Obagi, Merz Aesthetics and Allergan Aesthetics. Most recently, Hartman was president of Hugel Aesthetics where he oversaw the consecutive approval and commercialization of their neurotoxin across the US, Canada and Australia.

Keep Up With Our Content. Subscribe To Happi Newsletters